Skip to main content
Announcement | Argonne National Laboratory

COVID-19/Coronavirus Precautionary Site Access Restrictions

To protect the health and wellbeing of Argonne National Laboratory employees, collaborators, and visitors, we continue to assess and adjust our response to the COVID-19/coronavirus outbreak. We rely on guidance from the Centers for Disease Control and Prevention (CDC) to ensure that our decisions reflect the most current and accurate information.

Argonne National Laboratory requests that users and visitors who have traveled from or through a foreign country for which the CDC has issued a Warning Level 3 notice (avoid all nonessential travel) reschedule their visit to Argonne for a time at least 15 days after the date of their arrival in the United States.

We continue to ask all users and visitors who are ill, particularly if they are exhibiting respiratory symptoms, including fever, cough, and shortness of breath, to reschedule their visit and seek medical guidance.

This is a temporary measure that will help Argonne maintain a safe, healthy, and productive workplace. We appreciate your patience and willingness to minimize the spread of this virus.

Please check back with us for updates.